AC Immune shares are trading higher after the company announced it will receive the second ReTain-related milestone payment under its agreement with Janssen Pharmaceuticals.
Portfolio Pulse from Benzinga Newsdesk
AC Immune shares rose following the announcement of receiving a milestone payment from Janssen Pharmaceuticals under their ReTain agreement.
September 17, 2024 | 11:52 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AC Immune's stock price increased after the company announced it will receive a milestone payment from Janssen Pharmaceuticals, indicating positive progress in their ReTain agreement.
The announcement of a milestone payment from Janssen Pharmaceuticals is a positive indicator of progress in AC Immune's ReTain agreement, likely boosting investor confidence and driving the stock price up.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90